Skip to main content
Back to National Science Foundation

National Science Foundation's Therapeutics Portfolio

Browse 5 Therapeutics companies funded by National Science Foundation. See funding amounts, founder contacts, and investment details.

Therapeutics Companies
5
Total Funding in Therapeutics
$113.9M

Therapeutics Portfolio Companies (5)

Export
BiotechnologyHealth CareTherapeutics

Remedium Bio is a gene therapy company focused on the development of highly innovative treatments for a broad range of diseases.

Needham, United States
May 2026
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Ansa Biotechnologies develops a novel DNA synthesis technology based on enzymes.

Emeryville, United States
October 2025
$45.2M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareTherapeutics

FYR Diagnostics develops biomarker detection technology to combat chronic diseases in both human healthcare and agriculture.

Missoula, United States
September 2025
$8.0M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

Assistive TechnologyBiotechnologyeSportsGamingLife ScienceMedicalMedical DeviceMilitaryNeuroscienceTherapeutics

Sharper Sense is a wearable patch that stimulates a neck nerve to improve hearing, vision, and touch.

New York, United States
May 2025
$745K
Seed

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BiopharmaBiotechnologyGeneticsNanotechnologyPharmaceuticalTherapeutics

BreezeBio is a biotechnology business that creates genetic therapies using precision, non-viral delivery across clinically important tissues

Brisbane, United States
February 2026
$60.0M
Series B

Founder Contacts

19,000+ verified contacts

Explore National Science Foundation's Full Portfolio

View all companies funded by National Science Foundation across every industry and funding stage.

View Full National Science Foundation Portfolio